• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDSPLUS VIO 8X45 M3 CTB-1 CR::-HOT ROOM 2-0; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDSPLUS VIO 8X45 M3 CTB-1 CR::-HOT ROOM 2-0; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Catalog Number PDPB739Z
Device Problem Device Contaminated During Manufacture or Shipping (2969)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/17/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.The product upon which this medwatch is based has been received, however, the product evaluation is not yet complete.Any further information derived from the evaluation will be submitted in a supplemental 3500a form.(b)(4).The following information was requested, but unavailable: lot number? trade name: irgacare®.Active ingredient(s): triclosan.Dosage form: suture/solid/parenteral.Strength: = 2360 g/m.
 
Event Description
It was reported that a patient underwent an unknown procedure on (b)(6) 2021 and suture was used.During the procedure, when removing paper after the package was opened, it was found that there had been a hair.There were no adverse consequences to the patient.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Date sent to the fda: 7/20/2021.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803.Part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 component code: g07002 ¿ conforming device.Additional h3 investigation summary: one winding former with eight needle/suture combinations of product code pdpb739z was returned for analysis.The paper lid and the foil packaging were not received.Upon initial inspection to the sample no foreign matter or defects were observed on the sample received.The manufacturing records couldn't be reviewed as the batch number is unknown.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDSPLUS VIO 8X45 M3 CTB-1 CR::-HOT ROOM 2-0
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
MDR Report Key11991678
MDR Text Key259044689
Report Number2210968-2021-05495
Device Sequence Number1
Product Code NEW
Combination Product (y/n)Y
PMA/PMN Number
K061037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue NumberPDPB739Z
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/10/2021
Date Manufacturer Received06/23/2021
Patient Sequence Number1
-
-